EMPHYSEMATOUS CYSTITIS

This adverse event was reported 213 times

EMPHYSEMATOUS CYSTITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METYROSINE 1 0.0123
1 ANORECTAL OINTMENT 1 0.0046
2 BETAXOLOL HYDROCHLORIDE 1 0.0019
3 AMPICILLIN AND SULBACTAM 1 0.0011
4 SATRALIZUMAB 2 0.0011
5 FLUTAMIDE 1 0.0010
6 METYRAPONE 1 0.0010
7 PIOGLITAZONE HYDROCHLORIDE 1 0.0008
8 EPCORITAMAB-BYSP 1 0.0007
9 HYALURONATE SODIUM 1 0.0007
See all drugs enriched for association with EMPHYSEMATOUS CYSTITIS